Venture
Seaport Therapeutics, Inc.
Latest Form D 2024-10-31- CIK 2042347
- State MA
- Biotechnology
- 1 Form D offering since 2024-10-31
- Total sold
- $226M
- across its one offering
- Rounds
- 1
- Form D offerings since 2024-10-31
- Latest round
- $226M
- 2024-10-31 · 021-528276
- Investors
- 33
- on the latest round
Connected
named in its Form D filingsOfferings · since 2024-10-311 Form D offeringExemptions506(b)People · Item 3Daphne Zohar + 12 moreInvestors · dashboard2 inferred investors
Seaport Therapeutics, Inc.CIK 2042347
Round timeline
amount sold · by first filed2024-10-31 · $226M
- 2024-10-31$226M021-528276
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($226M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-528276 | First filed2024-10-31 | Latest2024-10-31 | Sought$226M | Sold$226M | Investors33 | Exemptions506(b) |
Who backs Seaport Therapeutics, Inc. — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-10-31
| Name | Relationship |
|---|---|
| Daphne Zohar | RelationshipExecutive Officer, Director |
| Michael Chen | RelationshipExecutive Officer |
| Eric Green | RelationshipExecutive Officer |
| Antony Loebel | RelationshipExecutive Officer |
| Lana Gladstein | RelationshipExecutive Officer |
| Steven Paul | RelationshipDirector |
| Eric Elenko | RelationshipDirector |
| James I. Healy | RelationshipDirector |
| Robert Nelsen | RelationshipDirector |
| Denice Torres | RelationshipDirector |
| David Wheadon | RelationshipDirector |
| Jason Pitts | RelationshipDirector |
| Bharatt Chowrira | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Massachusetts (MA)
- Exemptions
- Rule 506(b)
- First filed
- 2024-10-31
- Latest filing
- 2024-10-31
Who backs Seaport Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗